Preservation of vascular integrity in organs perfused in vitro with a platelet-rich medium.

PubWeight™: 2.16‹?› | Rank: Top 2%

🔗 View Article (PMID 5775827)

Published in Nature on April 05, 1969

Authors

M A Gimbrone, R H Aster, R S Cotran, J Corkery, J H Jandl, J Folkman

Articles citing this

Sphingosine 1-phosphate promotes endothelial cell barrier integrity by Edg-dependent cytoskeletal rearrangement. J Clin Invest (2001) 5.05

Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg (1972) 4.37

Clonal growth of bovine vascular endothelial cells: fibroblast growth factor as a survival agent. Proc Natl Acad Sci U S A (1976) 3.74

Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 3.30

Cultured endothelial cells produce a platelet-derived growth factor-like protein. Proc Natl Acad Sci U S A (1983) 3.29

Contractile proteins of endothelial cells, platelets and smooth muscle. Am J Pathol (1973) 2.36

Inflammation induces hemorrhage in thrombocytopenia. Blood (2008) 2.28

Human endothelial cells in culture produce platelet-activating factor (1-alkyl-2-acetyl-sn-glycero-3-phosphocholine) when stimulated with thrombin. Proc Natl Acad Sci U S A (1984) 2.28

Cultured endothelial cells synthesize both platelet-activating factor and prostacyclin in response to histamine, bradykinin, and adenosine triphosphate. J Clin Invest (1985) 2.16

Sphingosine 1-phosphate receptor regulation of N-cadherin mediates vascular stabilization. Genes Dev (2004) 2.16

Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. Blood (2011) 1.64

Regulation of vascular permeability by sphingosine 1-phosphate. Microvasc Res (2008) 1.62

Granulocyte macrophage colony-stimulating factor inhibits breast cancer growth and metastasis by invoking an anti-angiogenic program in tumor-educated macrophages. Cancer Res (2009) 1.57

Resistance to arteriosclerosis in pigs with von Willebrand's disease. Spontaneous and high cholesterol diet-induced arteriosclerosis. J Clin Invest (1978) 1.49

Tumor dormancy due to failure of angiogenesis: role of the microenvironment. Clin Exp Metastasis (2008) 1.38

Platelets play an important role in TNF-induced microvascular endothelial cell pathology. Am J Pathol (1997) 1.35

How platelets safeguard vascular integrity. J Thromb Haemost (2011) 1.32

The vascular endothelium-pathobiologic significance. Am J Pathol (1978) 1.30

Thrombosis induced in vivo in the mesenteric artery of normal and thrombocytopenic rats, an electron-microscopic study of the early arterial wall reaction. Br J Exp Pathol (1977) 1.29

Innate immune cells induce hemorrhage in tumors during thrombocytopenia. Am J Pathol (2009) 1.16

Role of platelet adhesion in homeostasis and immunopathology. Mol Pathol (1997) 1.16

Mac-1 (CD11b/CD18) links inflammation and thrombosis after glomerular injury. Circulation (2009) 1.15

Quantitative proteomics analysis of human endothelial cell membrane rafts: evidence of MARCKS and MRP regulation in the sphingosine 1-phosphate-induced barrier enhancement. Mol Cell Proteomics (2007) 1.13

Looking for the Word "Angiogenesis" in the History of Health Sciences: From Ancient Times to the First Decades of the Twentieth Century. World J Surg (2017) 1.06

Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury. Am J Respir Cell Mol Biol (2013) 1.02

Platelet mimetic particles for targeting thrombi in flowing blood. Adv Mater (2012) 0.98

Blood cells and endothelial barrier function. Tissue Barriers (2015) 0.94

Characterization and partial purification of an endothelial cell growth factor from human platelets. J Clin Invest (1984) 0.90

Judah Folkman, a pioneer in the study of angiogenesis. Angiogenesis (2008) 0.90

Erythrocyte-derived sphingosine-1-phosphate stabilizes basal hydraulic conductivity and solute permeability in rat microvessels. Am J Physiol Heart Circ Physiol (2012) 0.87

The isolated perfused lung. Environ Health Perspect (1984) 0.85

Twenty-four hour renal preservation and perfusion utilizing platelet-rich plasma. Ann Surg (1971) 0.85

From antiangiogenesis to hypoxia: current research and future directions. Cancer Manag Res (2010) 0.84

Human platelets modulate edema formation in isolated rabbit lungs. J Clin Invest (1989) 0.84

FTY720 (s)-phosphonate preserves sphingosine 1-phosphate receptor 1 expression and exhibits superior barrier protection to FTY720 in acute lung injury. Crit Care Med (2014) 0.81

A novel canine model of immune thrombocytopenia: has immune thrombocytopenia (ITP) gone to the dogs? Br J Haematol (2014) 0.75

Apolipoprotein A-I Modulates Atherosclerosis Through Lymphatic Vessel-Dependent Mechanisms in Mice. J Am Heart Assoc (2017) 0.75

Articles by these authors

Tumor angiogenesis: therapeutic implications. N Engl J Med (1971) 35.36

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell (1996) 23.99

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma. N Engl J Med (1991) 19.46

Angiogenic factors. Science (1987) 15.22

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell (1997) 13.94

Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell (1994) 13.76

What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst (1990) 13.41

Role of cell shape in growth control. Nature (1978) 12.46

Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science (1989) 10.70

Identification of an inducible endothelial-leukocyte adhesion molecule. Proc Natl Acad Sci U S A (1987) 10.43

Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines. J Clin Invest (1985) 8.70

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst (1992) 8.69

Overlapping patterns of activation of human endothelial cells by interleukin 1, tumor necrosis factor, and immune interferon. J Immunol (1986) 8.22

Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (1997) 7.66

Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med (1995) 7.37

Isolation of a tumor factor responsible for angiogenesis. J Exp Med (1971) 7.12

Culture of vascular endothelium. Prog Hemost Thromb (1976) 7.05

Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol (1993) 6.55

Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci U S A (1994) 6.48

Red cells coated with immunoglobulin G: binding and sphering by mononuclear cells in man. Science (1967) 6.42

Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res (2000) 6.42

The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell (1997) 6.34

Human vascular endothelial cells in culture. Growth and DNA synthesis. J Cell Biol (1974) 5.95

Interleukin 1 (IL-1) induces biosynthesis and cell surface expression of procoagulant activity in human vascular endothelial cells. J Exp Med (1984) 5.89

Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: characterization and comparison with the actions of interleukin 1. Proc Natl Acad Sci U S A (1986) 5.83

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science (1991) 5.76

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy. Am J Ophthalmol (1994) 5.76

Long-term culture of capillary endothelial cells. Proc Natl Acad Sci U S A (1979) 5.70

Tumor angiogenesis. Adv Cancer Res (1985) 5.66

Two distinct monokines, interleukin 1 and tumor necrosis factor, each independently induce biosynthesis and transient expression of the same antigen on the surface of cultured human vascular endothelial cells. J Immunol (1986) 5.57

Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res (1977) 5.19

Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature (1990) 5.15

Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest (1995) 5.09

Cytokines and endothelial cell biology. Physiol Rev (1990) 5.02

Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon. J Exp Med (1983) 4.92

Effects of angiogenesis inhibitors on multistage carcinogenesis in mice. Science (1999) 4.91

Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol (1989) 4.85

Endothelial cell-derived basic fibroblast growth factor: synthesis and deposition into subendothelial extracellular matrix. Proc Natl Acad Sci U S A (1987) 4.83

Interferon alfa-2a therapy for life-threatening hemangiomas of infancy. N Engl J Med (1992) 4.76

Angiogenesis in vitro. Nature (1980) 4.46

Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc Natl Acad Sci U S A (1984) 4.43

Anti-angiogenesis: new concept for therapy of solid tumors. Ann Surg (1972) 4.37

Tumor dormancy in vivo by prevention of neovascularization. J Exp Med (1972) 4.34

Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science (1984) 4.27

The dynamic response of vascular endothelial cells to fluid shear stress. J Biomech Eng (1981) 4.27

MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature (1999) 4.19

Lymphocytes recognize human vascular endothelial and dermal fibroblast Ia antigens induced by recombinant immune interferon. Nature (1983) 4.16

Tumor growth and neovascularization: an experimental model using the rabbit cornea. J Natl Cancer Inst (1974) 4.05

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J Exp Med (1988) 4.02

Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci U S A (1996) 3.93

Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol (1994) 3.76

Activated macrophages induce vascular proliferation. Nature (1977) 3.74

Induction and detection of a human endothelial activation antigen in vivo. J Exp Med (1986) 3.66

Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med (1996) 3.64

Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst (1995) 3.53

Angiogenesis inhibitors endostatin or TNP-470 reduce intimal neovascularization and plaque growth in apolipoprotein E-deficient mice. Circulation (1999) 3.53

A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci (1996) 3.49

The role of endothelial cells in inflammation. Transplantation (1990) 3.47

Leukocytosis and resistance to septic shock in intercellular adhesion molecule 1-deficient mice. J Exp Med (1994) 3.32

Relation of vascular proliferation to tumor growth. Int Rev Exp Pathol (1976) 3.21

Exchange of heme among hemoglobins and between hemoglobin and albumin. J Biol Chem (1968) 3.09

Activation of cultured human endothelial cells by recombinant lymphotoxin: comparison with tumor necrosis factor and interleukin 1 species. J Immunol (1987) 3.06

Leukocyte adhesion molecule-1 (LAM-1, L-selectin) interacts with an inducible endothelial cell ligand to support leukocyte adhesion. J Immunol (1991) 3.05

Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins. J Cell Biol (1975) 3.04

Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, beta 1-integrins, and beta 2-integrins. J Cell Biol (1994) 3.02

A mononuclear cell component in experimental immunological glomerulonephritis. J Exp Med (1978) 3.02

Tumor behavior in isolated perfused organs: in vitro growth and metastases of biopsy material in rabbit thyroid and canine intestinal segment. Ann Surg (1966) 3.00

Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest (1994) 2.97

Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. Arch Ophthalmol (1996) 2.95

Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection. J Clin Invest (1970) 2.92

IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol (1992) 2.89

Biomechanical activation of vascular endothelium as a determinant of its functional phenotype. Proc Natl Acad Sci U S A (2001) 2.89

Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci U S A (1997) 2.88

Self-regulation of growth in three dimensions. J Exp Med (1973) 2.87

Deficiency of C3 inactivator in man. J Immunol (1971) 2.86

Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease. Lancet (1989) 2.86

How does extracellular matrix control capillary morphogenesis? Cell (1989) 2.84

Pathogenesis of polycation-induced alterations ("fusion") of glomerular epithelium. Lab Invest (1977) 2.82

Polymers for the sustained release of proteins and other macromolecules. Nature (1976) 2.81

Comparative evaluation of the antitumor activity of antiangiogenic proteins delivered by gene transfer. Proc Natl Acad Sci U S A (2001) 2.81

A role for smad6 in development and homeostasis of the cardiovascular system. Nat Genet (2000) 2.80

Endothelial-leukocyte adhesion molecule-1-dependent and leukocyte (CD11/CD18)-dependent mechanisms contribute to polymorphonuclear leukocyte adhesion to cytokine-activated human vascular endothelium. J Immunol (1989) 2.80

Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol (1991) 2.77

An atherogenic diet rapidly induces VCAM-1, a cytokine-regulatable mononuclear leukocyte adhesion molecule, in rabbit aortic endothelium. Arterioscler Thromb (1993) 2.77

Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J Exp Med (1991) 2.76

Turbulent fluid shear stress induces vascular endothelial cell turnover in vitro. Proc Natl Acad Sci U S A (1986) 2.73